ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, though we can't authenticate the accuracy of the following post from Cafepharma. It looks like your opinion regarding MNK and Acthar is materializing.

In 2023, tons of Acthar sales reps, reimbursement people, and other key people have bailed. It’s not like two or three people have left. It’s half the reimbursement team and sales is losing one rep nearly every week.

The company canned the remaining two Reimbursement Directors and earlier, they canned a sales director or two.

The company was pretty decent 6-10 years ago, but endless poor management decisions have led us to the brink of total failure. MNK sucks. It sucks badly, morale is the worst and communication is non-existant. No one has a solid plan to fix anything either.

Cafepharma Post